Papillary renal cell carcinoma: Difference between revisions
Jump to navigation
Jump to search
Templated |
m →Microscopic examination: Cleanup |
||
| (6 intermediate revisions by the same user not shown) | |||
| Line 8: | Line 8: | ||
==Microscopic examination== | ==Microscopic examination== | ||
Papillary renal cell carcinoma has | Papillary renal cell carcinoma has the following main characteristics: | ||
<gallery mode=packed heights=210> | |||
File:Histopathology of papillary renal cell carcinoma type 1.jpg|Papillary architecture, small-to-medium-sized cells, foamy macrophages in fibrovascular cores.<ref name="SirohiSmith2018">{{cite journal|last1=Sirohi|first1=Deepika|last2=Smith|first2=Steven C.|last3=Agarwal|first3=Neeraj|last4=Maughan|first4=Benjamin L.|title=Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities|journal=Research and Reports in Urology|volume=Volume 10|year=2018|pages=205–217|issn=2253-2447|doi=10.2147/RRU.S154932}}</ref> | |||
File:Histopathology of papillary renal cell carcinoma type 1, grade 2, with variable density.jpg|This case being more compact at right. | |||
File:Histopathology of papillary renal cell carcinoma type 2.jpg|It may lack foamy macrophages and have pseudostratified nuclei.<ref name="SirohiSmith2018"/><ref group=note>Papillary renal cell carcinoma lacking foamy macrophages and having pseudostratified nuclei was previously classified as type 2, but this is no longer recommended.<br>- {{cite journal| author=Lobo J, Ohashi R, Amin MB, Berney DM, Compérat EM, Cree IA | display-authors=etal| title=WHO 2022 landscape of papillary and chromophobe renal cell carcinoma. | journal=Histopathology | year= 2022 | volume= 81 | issue= 4 | pages= 426-438 | pmid=35596618 | doi=10.1111/his.14700 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=35596618 }} </ref> | |||
</gallery> | |||
Even if the histology favors the diagnosis, it is generally appropriate to perform confirmatory '''[[immunohistochemistry]]''': | |||
*PAX-2 (typically positive), TTF-1 and thyroglobulin (typically negative) to confirm renal rather than a metastatic [[papillary thyroid carcinoma]]. | |||
*CK-7 and P504S/AMACR (both typically positive) to confirm the histologic type versus [[clear cell papillary]] and [[clear cell renal cell carcinoma]]. | |||
===Grading=== | ===Grading=== | ||
| Line 27: | Line 27: | ||
*'''Grade 3''': Clearly visible nucleoli (arrow) at ×100 magnification. | *'''Grade 3''': Clearly visible nucleoli (arrow) at ×100 magnification. | ||
*'''Grade 4''': Extreme pleomorphism or rhabdoid and/or sarcomatoid morphology. | *'''Grade 4''': Extreme pleomorphism or rhabdoid and/or sarcomatoid morphology. | ||
<noinclude> | |||
===Staging=== | |||
{{Renal tumor staging}}</noinclude> | |||
==Microscopy report== | ==Microscopy report== | ||
| Line 40: | Line 43: | ||
*Papillary renal cell carcinoma, 3.2 cm in greatest dimension, ISUP/WHO grade 2. | *Papillary renal cell carcinoma, 3.2 cm in greatest dimension, ISUP/WHO grade 2. | ||
*Surgical margins are negative for carcinoma. | *Surgical margins are negative for carcinoma. | ||
|} | |||
{{Renal cell carcinoma - synoptic report}} | {{Renal cell carcinoma - synoptic report}} | ||
{{Bottom}} | |||